S2560 Real-World Comparative Outcomes of Nivolumab + Ipilimumab Versus Atezolizumab + Bevacizumab in Advanced Hepatocellular Carcinoma: A TriNetx Study
Year: 2025
Type: conference-abstract
Authors: Sameh Gomaa, Hatem Ahmed, Imad Alabdul Razzak, Eyad Abdulrazzak
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7114783165
Cites:
Cited by:
Related to:
